SMMT Summit Therapeutics Inc.

Fundamentals / CIK 0001599298 / USD

Summit Therapeutics Inc. reported $692.9M in total assets and a net loss of $832.7M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SMMT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2019 to 2025), reported in USD.

$170.3M$85.14M$0-$1.01BFY 2019 Revenue: $57.09MFY 2019 Net Income: $10.87M2019FY 2019 Revenue: $743KFY 2019 Net Income: -$29.13M2019FY 2020 Revenue: $860KFY 2020 Net Income: -$52.70M2020FY 2021 Revenue: $1.81MFY 2021 Net Income: -$88.60M2021FY 2022 Revenue: $705KFY 2022 Net Income: -$78.78M2022FY 2023 Revenue: $0FY 2023 Net Income: -$614.9M2023FY 2024 Revenue: $0FY 2024 Net Income: -$221.3M2024FY 2025 Net Income: -$1.08B2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jan 31
Revenue -- $0 $0 $705K $1.81M $860K $743K $57.09M
Research & Development $537.7M $150.8M $59.47M $52.00M $85.35M $53.27M $39.81M $52.00M
Total Operating Expenses $1.09B $226.0M $609.6M $87.21M $109.0M $73.36M $51.09M $74.31M
Operating Income -$1.09B -$226.0M -$609.6M -$72.09M -$86.19M -$53.19M -$27.47M $5.39M
EBITDA -$1.09B -$225.9M -$609.5M -$70.83M -$84.84M -$51.64M -$26.18M $6.90M
Interest Income -- -- -- $1.51M $0 $4.0K $5.0K $5.0K
Interest Expense $0 $8.69M $16.46M $4.40M $242K $255K $291K $620K
Income Before Tax -$1.08B -$221.3M -$614.9M -$78.78M -$88.60M -$52.91M -$29.09M $9.08M
Income Tax Expense $0 $0 $0 -- $0 -$213K $36K -$1.79M
Net Income -$1.08B -$221.3M -$614.9M -$78.78M -$88.60M -$52.70M -$29.13M $10.87M
Basic EPS -$1.44 -$0.31 -$0.99 -$0.41 -$0.67 -$0.53 -$0.62 $0.44
Diluted EPS -$1.44 -$0.31 -$0.99 -$0.41 -$0.67 -$0.53 -$0.62 $0.44
Basic Shares Outstanding 747.7M 718.5M 619.6M 193.3M 131.7M 99.3M 46.9M 24.5M
Diluted Shares Outstanding 747.7M 718.5M 619.6M 193.3M 131.7M 99.3M 46.9M 24.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $169.1M $157.7M $132.6M $147.3M $131.1M $208.0M $51.27M $51.38M
Total Operating Expenses $214.6M $220.5M $195.2M $224.9M $234.2M $568.4M $66.85M $65.61M
Operating Income -- -- -- -- -- -- -- -$65.61M
EBITDA -- -- -- -- -- -- -- -$65.59M
Interest Expense -- -- -- $0 $0 $0 $0 $9.0K
Net Income -$208.4M -$215.7M -$189.4M -$219.2M -$231.8M -$565.7M -$62.91M -$61.20M
Basic EPS -$0.26 -$0.28 -$0.24 -- -$0.31 -$0.76 -$0.09 --
Diluted EPS -$0.26 -$0.28 -$0.24 -- -$0.31 -$0.76 -$0.09 --
Basic Shares Outstanding 798.2M 778.2M 775.5M -- 743.4M 742.6M 738.1M --
Diluted Shares Outstanding 798.2M 778.2M 775.5M -- 743.4M 742.6M 738.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $225.3M $104.9M $71.42M $348.6M $71.79M $66.42M $63.84M
Short-Term Investments $488.2M $307.5M $114.8M $0 -- -- --
Cash & Short-Term Investments $713.4M $412.3M $186.2M $348.6M $71.79M $66.42M $63.84M
Accounts Receivable, Net -- -- $0 $349K $1.46M $331K $541K
Other Current Assets -- -- $181K $486K $1.20M $1.52M $1.40M
Total Current Assets $720.3M $423.8M $189.7M $656.7M $97.31M $87.67M $79.63M
Property, Plant & Equipment, Net $1.06M $254K $204K $906K $694K $725K $518K
Goodwill $2.00M $1.86M $1.89M $1.80M $2.01M $2.03M $1.96M
Intangible Assets -- $0 $0 $0 $10.40M $11.52M $13.12M
Other Non-Current Assets $7.21M $2.55M $4.32M $577K $170K $0 --
Total Non-Current Assets $30.88M $11.81M $13.24M $7.46M $16.06M $14.82M $16.62M
Total Assets $751.2M $435.6M $202.9M $664.2M $113.4M $102.5M $96.25M
Accounts Payable $20.29M $4.64M $2.67M $355K $4.37M $6.14M $4.47M
Deferred Revenue (Current) -- -- -- $0 $7.94M $8.37M $2.62M
Other Current Liabilities $2.28M $1.80M $717K $662K $897K $729K $366K
Total Current Liabilities $72.99M $41.73M $20.41M $38.78M $25.62M $19.89M $13.77M
Deferred Revenue (Non-Current) -- -- -- $0 $0 $569K $493K
Other Non-Current Liabilities $1.83M $1.63M $1.56M $1.43M $2.78M $2.51M $2.70M
Total Non-Current Liabilities $19.33M $5.08M $104.9M $498.7M $4.47M $3.15M $3.62M
Total Liabilities $92.32M $46.81M $125.3M $537.5M $30.09M $23.05M $17.39M
Total Debt (incl. Leases) $20.89M $7.22M $6.10M $4.45M $2.78M $465K $893K
Common Stock $7.75M $7.38M $7.02M $2.11M $980K $826K $672K
Retained Earnings -$2.29B -$1.21B -$993.3M -$378.3M -$299.5M -$210.9M -$158.2M
Accumulated Other Comp. Income -$2.54M -$2.29M -$2.45M -$1.89M -$2.20M -$3.79M -$4.76M
Total Stockholders' Equity $658.9M $388.7M $77.69M $126.7M $83.28M $79.45M $78.86M
Total Equity $658.9M $388.7M $77.69M $126.7M $83.28M $79.45M $78.86M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $150.8M $419.4M $106.5M $225.3M $238.6M $297.9M $211.5M $104.9M
Short-Term Investments $479.0M $271.3M $492.2M $488.2M $0 $0 $149.8M $307.5M
Cash & Short-Term Investments $629.8M $690.7M $598.7M $713.4M $238.6M $297.9M $361.3M $412.3M
Total Current Assets $660.7M $720.6M $616.6M $720.3M $246.5M $309.2M $370.8M $423.8M
Property, Plant & Equipment, Net $2.53M $1.78M $1.66M $1.06M $810K $690K $652K $254K
Goodwill $1.98M $1.97M $1.97M $2.00M $2.00M $2.04M $1.92M $1.86M
Intangible Assets -- -- -- -- -- -- -- $0
Other Non-Current Assets $8.96M $8.45M $8.23M $7.21M $7.03M $6.52M $4.14M $2.55M
Total Non-Current Assets $32.12M $31.61M $31.26M $30.88M $15.26M $14.80M $13.07M $11.81M
Total Assets $692.9M $752.2M $647.9M $751.2M $261.7M $324.0M $383.8M $435.6M
Accounts Payable $32.72M $22.90M $27.55M $20.29M $22.25M $22.98M $4.99M $4.64M
Other Current Liabilities $1.83M $2.62M $1.15M $2.28M $1.96M $1.49M $759K $1.80M
Total Current Liabilities $110.2M $103.6M $83.27M $72.99M $64.93M $60.33M $34.88M $41.73M
Other Non-Current Liabilities $1.81M $1.80M $1.80M $1.83M $1.83M $1.84M $1.71M $1.63M
Total Non-Current Liabilities $17.94M $18.64M $18.66M $19.33M $4.54M $4.27M $4.62M $5.08M
Total Liabilities $128.2M $122.2M $101.9M $92.32M $69.47M $64.60M $39.49M $46.81M
Total Debt (incl. Leases) $19.98M $20.38M $20.04M $20.89M $5.43M $5.55M $6.45M $7.22M
Common Stock $8.00M $7.93M $7.76M $7.75M $7.44M $7.43M $7.42M $7.38M
Retained Earnings -$2.91B -$2.70B -$2.48B -$2.29B -$2.07B -$1.84B -$1.28B -$1.21B
Accumulated Other Comp. Income -$2.70M -$2.67M -$2.63M -$2.54M -$2.71M -$2.75M -$2.56M -$2.29M
Total Stockholders' Equity $564.7M $630.0M $545.9M $658.9M $192.3M $259.4M $344.3M $388.7M
Total Equity $564.7M $630.0M $545.9M $658.9M $192.3M $259.4M $344.3M $388.7M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jan 31
Net Income -$1.08B -$221.3M -$614.9M -$78.78M -$88.60M -$52.70M -$29.13M $10.87M
Depreciation & Amortization $146K $89K $198K $1.26M $1.35M $1.55M $1.29M $1.51M
Stock-Based Compensation $732.4M $50.98M $14.11M $11.95M $12.80M $1.77M $845K $6.29M
Change in Receivables -- $0 $359K $975K -$1.14M $212K $5.44M -$2.47M
Change in Payables $15.30M $2.02M $2.26M -$4.13M -$1.71M $1.64M -$1.31M -$10K
Operating Cash Flow -$322.9M -$142.1M -$76.76M -$41.58M -$72.59M -$48.11M -$20.76M -$35.11M
Capital Expenditure -$657K -$139K -$128K -$624K -$306K -$421K -$205K -$157K
Free Cash Flow -$323.6M -$142.2M -$76.89M -$42.21M -$72.89M -$48.53M -$20.96M -$35.26M
Investing Cash Flow -$174.3M -$205.3M -$587.8M -$624K -$306K -$421K -$341K -$331K
Common Stock Issued -- -- $104.7M $100.0M $75.00M $50.00M $50.41M $46.08M
Dividends Paid -- -- -- -- -- $0 $0 $0
Financing Cash Flow $617.5M $381.2M $86.51M $620.2M $77.92M $50.55M $49.51M $44.51M
Net Change in Cash $120.4M $33.76M -$577.2M $576.8M $5.37M $2.58M $28.60M $6.75M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$208.4M -$215.7M -$189.4M -$219.2M -$231.8M -$565.7M -$62.91M -$61.20M
Depreciation & Amortization $85K $46K $44K $42K $42K $37K $25K $22K
Stock-Based Compensation $47.69M $68.71M $72.79M $111.8M $130.8M $478.8M $11.10M $11.02M
Change in Receivables -- -- -- -- -- -- -- $0
Change in Payables $9.82M -$3.91M $6.80M -$2.15M -$839K $17.93M $356K $1.53M
Operating Cash Flow -$159.8M -$141.1M -$122.3M -$101.9M -$93.08M -$66.74M -$61.17M -$48.67M
Capital Expenditure -$396K -$909K -$245K -$164K -$71K $0 -$422K -$14K
Free Cash Flow -$160.2M -$142.0M -$122.5M -$102.1M -$93.15M -$66.74M -$61.59M -$48.69M
Investing Cash Flow -$204.2M $222.9M -$238K -$485.2M -$71K $150.8M $160.1M $83.48M
Financing Cash Flow $95.43M $231.1M $3.80M $573.8M $33.81M $2.22M $7.68M -$23.61M
Net Change in Cash -$268.6M $312.9M -$118.8M -$13.29M -$59.32M $86.35M $106.7M $11.09M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jan 31
Operating Margin -- -- -- -10225.4% -4764.3% -6185.2% -3697.6% 9.4%
Net Profit Margin -- -- -- -11174.8% -4897.8% -6127.6% -3920.2% 19.0%
Return on Equity (ROE) -163.9% -56.9% -791.5% -62.2% -106.4% -66.3% -36.9% --
Return on Assets (ROA) -143.7% -50.8% -303.0% -11.9% -78.2% -51.4% -30.3% --
Current Ratio 9.87x 10.15x 9.30x 16.93x 3.80x 4.41x 5.78x --
Quick Ratio 9.77x 9.88x 9.13x 9.00x 2.86x 3.36x 4.68x --
Debt to Equity 0.03x 0.02x 0.08x 0.04x 0.03x 0.01x 0.01x --
Revenue Growth (YoY) -- -- -100.0% -61.0% +110.3% +15.7% -98.7% --
Operating Income Growth (YoY) -- -- -- -- -- -- -609.8% --
Net Income Growth (YoY) -- -- -- -- -- -- -368.0% --
EPS Growth (YoY) -- -- -- -- -- -- -241.3% --
5Y Revenue / Share Growth -- -100.0% -100.0% -- -- -- -- --
5Y Net Income / Share Growth -- -- -323.5% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -147.5% -135.9% -220.9% -163.9% -479.4% -287.6% -69.9% -56.9%
Return on Assets (ROA) -120.2% -113.8% -186.2% -143.7% -352.1% -230.2% -62.7% -50.8%
Current Ratio 5.99x 6.96x 7.41x 9.87x 3.80x 5.13x 10.63x 10.15x
Quick Ratio 5.71x 6.67x 7.19x 9.77x 3.67x 4.94x 10.36x 9.88x
Debt to Equity 0.04x 0.03x 0.04x 0.03x 0.03x 0.02x 0.02x 0.02x
Source: SEC EDGAR CompanyFacts (CIK 0001599298) · from January 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:08 UTC · Open in terminal